UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 207

Sortiert nach

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.433-440

2012

Volltextzugriff (PDF)

Various impacts of driver mutations on the PD-L1 expression of NSCLC

PloS one, 2022-08, Vol.17 (8), p.e0273207-e0273207

2022

Volltextzugriff (PDF)

Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.282-290

2018

Volltextzugriff (PDF)

The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Scientific reports, 2021-06, Vol.11 (1), p.12084-12084, Article 12084

2021

Volltextzugriff (PDF)

ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

Scientific reports, 2020-12, Vol.10 (1), p.21063-21063, Article 21063

2020

Volltextzugriff (PDF)

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma

PloS one, 2018-11, Vol.13 (11), p.e0207001-e0207001

2018

Volltextzugriff (PDF)

PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

Scientific reports, 2022-06, Vol.12 (1), p.9753-9753, Article 9753

2022

Volltextzugriff (PDF)

HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages

eLife, 2022-08, Vol.11

2022

Volltextzugriff (PDF)

JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer

PloS one, 2016-03, Vol.11 (3), p.e0150355-e0150355

2016

Volltextzugriff (PDF)

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan

PloS one, 2015-03, Vol.10 (3), p.e0120852-e0120852

2015

Volltextzugriff (PDF)

Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission

Biomedicine & pharmacotherapy, 2023-06, Vol.162, p.114616-114616, Article 114616

2023

Volltextzugriff (PDF)

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

American journal of respiratory and critical care medicine, 2011-04, Vol.183 (8), p.1071-1079

2011

Volltextzugriff (PDF)

Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2064

2022

Volltextzugriff (PDF)

High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation

Disease models & mechanisms, 2023-11, Vol.16 (11)

2023

Volltextzugriff (PDF)

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

Cancer medicine (Malden, MA), 2023-07, Vol.12 (13), p.14511-14525

2023

Volltextzugriff (PDF)

Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis

Lung cancer (Amsterdam, Netherlands), 2016-04, Vol.94, p.46-53

2016

Volltextzugriff (PDF)

HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma

PloS one, 2015-04, Vol.10 (4), p.e0124191-e0124191

2015

Volltextzugriff (PDF)

Association of Programmed Death‐Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma Receiving Crizotinib

The oncologist (Dayton, Ohio), 2020-08, Vol.25 (8), p.702-711

2020

Volltextzugriff (PDF)

EGFR mutation, smoking, and gender in advanced lung adenocarcinoma

Oncotarget, 2017-10, Vol.8 (58), p.98384-98393

2017

Volltextzugriff (PDF)

FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression

Clinical cancer research, 2018-02, Vol.24 (4), p.916-926

2018

Volltextzugriff (PDF)

The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Cancer Research and Treatment, 2018, 50(4), , pp.1294-1303

2018

Volltextzugriff (PDF)

Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Scientific reports, 2021-08, Vol.11 (1), p.17646-17646, Article 17646

2021

Volltextzugriff (PDF)

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes

Biomolecules (Basel, Switzerland), 2022-01, Vol.12 (2), p.160

2022

Volltextzugriff (PDF)

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid

Cancers, 2022-06, Vol.14 (12), p.2824

2022

Volltextzugriff (PDF)

Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models

Biomedicines, 2021-08, Vol.9 (9), p.1124

2021

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(98)
Humans
(63)
Male
(32)
Physical Sciences
(32)
Oncology
(30)
Female
(28)
Lung Cancer
(28)
Lung Neoplasms - Genetics
(27)
Animals
(24)
Science & Technology - Other Topics
(24)
Technology
(24)
Aged
(23)
Mutation
(22)
Chemistry
(21)
Middle Aged
(21)
Mice
(19)
Multidisciplinary Sciences
(18)
Lung Neoplasms - Drug Therapy
(16)
Adenocarcinoma
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

Various impacts of driver mutations on the PD-L1 expression of NSCLC

Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer

The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma

PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages

JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan

Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice

High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis

HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma

Association of Programmed Death‐Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma Receiving Crizotinib

EGFR mutation, smoking, and gender in advanced lung adenocarcinoma

FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression

The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid

Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models

Suchergebnisse filtern